Morgan Stanley raises Regeneron price target to $779
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
03:10:59 PM UTC
SquawkNews
Regeneron Pharma Price Target Raised to $779.00/Share From $758.00 by Morgan Stanley